NightHawk Biosciences Inc (NHWK)

[dia76ca]

You are correct...the data must continue to be good. I would expect the two upcoming presentations to review the current data to prepare the way for the Q4 release of new data. I hope they will tell us about the reason for the delay of the HS-110 and cyclophosphamide trial data. The most obvious explanation is that there is very good overall survival data. I look forward to learning more.

2016 Aegis Growth Conference

Date: Wednesday, September 21, 2016
Time: 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time)
Location: Encore at Wynn Las Vegas
Webcast: http://ir.heatbio.com/events-presentations. The webcast will be archived on the company’s website for a period of three months.

OktoberINVESTfest 5th Annual Investors Conference

Date: Wednesday, September 28, 2016
Time: 1:15 p.m. Eastern Time
Location: The New York Academy of Sciences